Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

TD Cowen analyst Charles Rhyee maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $250.00. The ...

TD Cowen analyst William Katz maintained a Hold rating on Affiliated Managers (AMG – Research Report) today and set a price target of $187.00.

Apple ( AAPL) supplier Skyworks Solutions ( SWKS) saw its stock drop nearly 25% Thursday as the semiconductor firm said that ...

CFO Jay Malave will participate in a fireside chat at the TD Cowen 46th Annual Aerospace & Defense Conference on Thursday, Feb. 13 at 8:30 a.m. to 9:10 a.m. ET.

TD Cowen expressed confidence in Pinterest Inc (NYSE:PINS), increasing the company's price target from $38.00 to $46.00 while maintaining a Buy rating. The decision came on the heels of Pinterest's ...

Investing.com-- TD Cowen analysts said claims from U.S. President Donald Trump- that the Federal Reserve failed to stop inflation, and that he would fix price pressures with policy instead- ...

There are reasons for optimism, said Gautam Khanna, an aerospace analyst with TD Cowen. Since Ortberg took the reins in early ...

Why are we forgetting history's lessons? We're told in school that we study history so as not to repeat its mistakes. But what if those lessons aren't sticking? Today's guest regularly invokes ...

Ippei Mizuhara, who last year agreed to plead guilty to bank fraud in connection with illegally transferring millions of dollars from Shohei Ohtani, is allegedly heard in a newly released ...

That’s according to TD Cowen’s annual report on the near-term outlook for U.S. drug prices. This year’s report, which incorporates findings from a survey of 27 health maintenance ...